Lower Suicide Risks in Adolescents With Obesity Taking GLP-1 Drugs
Regulatory agencies, including the US Food and Drug Administration, have evaluated reports of suicidal thoughts or actions in patients treated with glucagon-like peptide 1 (GLP-1) receptor agonists, but a recent review of the medical records of adolescents with obesity suggests that GLP-1 drugs do…